Advisory Councils

Corporate Advisory Council

The members of our Corporate Advisory Council provide collective input on IGT’s  priorities and engagement activities.

jnj_logo_rgb.jpg
FerGEne.png
logo 2.png
logo 3.png
logo 4.png
Avrobio-Logo_RGB.jpg
Astellas logo_full color.jpg

Patient Advocacy Advisory Council

Patient advocates across a number of diseases contribute important perspectives that help ensure patients’ interests are at the center of our work.

AARDA Logo.png
everylife.jpg
cure-duchenne-logo-1.png
CureSMA.png
NPAF.png
BCAN-logo-revised-tagline - Full Color.p
CMT.png
FARA.png
gaucher.png
Global genes.jpeg

  • Khrystal Davis, Rare Disease Advocate, Mother of son w/SMA, Founder of Texas Rare Alliance

  • Jenn McNary, Patient Advocate & Consultant

       Founder, One Rare

  • Seth Rotberg, Patient Advocate & Patient in Huntington Disease Co-Founder, Head of Strategy & Engagement of Our Odyssey

  • Rolf Benirschke, Survivor and Patient Advocate Crohn’s Disease, Ulcerative Colitis, Colorectal & Bladder Cancer
     

Scientific, Academic & Medical Council

The transformative and technical nature of gene therapies requires that healthcare providers, researchers and scientists lend their expertise and experience to the conversation.

rett.png
University Iowa - Gene Therapy Center.jp
GTP Penn Dual Logo.png
FFB_WEB_Full-Color.png
high res logo.png

The Institute for Gene Therapies advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. 

Get In Touch

IGT. © 2020 All Rights Reserved